|
시장보고서
상품코드
1558416
액체생검용 채혈관 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 : 제품별, 재료별, 용도별, 최종사용자별, 지역별Blood Collection Tubes for Liquid Biopsy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Material, Application, End User,and Geography |
||||||
폐사의 최신 조사 리포트 '액체생검용 채혈관 시장 예측(-2031년) : 세계 분석 - 제품별, 용도별, 재료별, 최종사용자별, 지역별'에 따르면 시장은 2023년 1억 1,013만 달러에서 성장하며, 2031년에는 4억 2,866만 달러에 달할 것으로 예측되며, 2023-2031년에 18.5%의 CAGR을 기록할 것으로 예측됩니다. 액체생검용 채혈 튜브 시장의 성장을 이끄는 가장 영향력 있는 요인으로는 전 세계 암 유병률 증가와 다른 진단 검사 기술에 비해 액체생검의 우위를 꼽을 수 있습니다. 그러나 숙련된 전문가의 부족은 시장 성장을 저해하는 요인으로 작용하고 있습니다. 액체생검의 기술 발전은 향후 수년간 액체생검용 채혈관의 새로운 시장 동향을 가져올 것으로 예상됩니다.
액체생검용 채혈 튜브는 제약 산업에서 가장 유망한 수단 중 하나이며, 다양한 질병과 질환을 치료할 수 있는 독특한 접근 방식을 제공합니다. 액체생검용 채혈 튜브 시장은 제약 및 생명공학 기업이 생산 설비 개선에 막대한 투자를 하고 있으므로 지속적으로 성장하고 있습니다. 만성질환 증가와 진단 건수 증가는 고급 진단 및 치료제의 접근성을 필요로 하며, 이는 전 세계 액체생검용 채혈관 시장을 촉진하고 있습니다. 또한 수요 증가, 혁신적 치료법 수용 확대, 임상시험 증가가 시장 성장의 원동력이 될 것으로 예상됩니다. 그러나 바이오시밀러의 승인은 액체생검용 채혈관 시장의 성장을 제한하는 주요 요인 중 하나입니다.
2023년 액체생검용 채혈관 세계 시장에서 북미가 큰 비중을 차지할 것으로 예상됩니다. 북미 액체생검용 혈액채취 튜브 시장은 미국, 캐나다, 멕시코로 구분됩니다. 기술적으로 진보된 제품의 빠른 수용, 활발한 연구개발 활동, 대규모 헬스케어 기업의 존재, 액체생검에 대한 FDA의 승인 건수 증가는 북미 액체생검용 채혈관 시장을 강화하는 주요 요인 중 하나입니다. 미국에서는 암 발병률의 급격한 증가, 혁신적인 진단 솔루션 개발에 대한 막대한 지출, 주요 시장 기업의 존재로 인해 액체생검 시술 시장이 빠르게 성장하고 있습니다. 미국 국립암연구소는 2024년 미국에서 200만 명의 암 환자가 새로 등록되고 61만 1,720명이 암으로 사망할 것으로 예측했습니다. 같은 자료에 따르면 매년 인구 10만 명당 440.5명이 암 진단을 받을 뻔한 것으로 나타났습니다. 조직 생검은 폐암 진단에 사용되는 침습적인 기술입니다. 이런 유형의 생검은 샘플 부족으로 인해 신뢰할 수 없는 결과를 초래할 수 있으므로 연구자들은 폐암 진단을 위한 액체생검 기술 개발에 집중하고 있습니다. 2022년 12월, Agilent Technologies Inc.는 KRAS G12C 변이가 있는 진행성 비소세포폐암(NSCLC) 환자를 식별하는 동반진단(CDx) 솔루션인 Agilent Resolution ctDx FIRST가 미국 FDA의 승인을 획득했습니다. 승인을 획득하였습니다. 미국 FDA의 액체생검 검사에 대한 이러한 승인은 미국내 액체생검용 채혈관 수요를 촉진할 것으로 보입니다.
암 모니터링에 액체생검을 활용하면 미래 시장 기회를 창출할 수 있습니다.
액체생검은 암의 성장을 모니터링하고, 유전자 돌연변이를 발견하고, 재발의 징후를 식별하고, 면역 요법에 대한 민감도를 예측하는 데 많은 관심을 받고 있습니다. 암의 조기 발견은 더 나은 결과를 가져옵니다. 예를 들어 조기 발견 환자는 말기 암이나 악성 암 환자보다 완치율과 생존율이 높습니다. 그러나 증상이 뚜렷하지 않은 초기 단계에서 암을 발견하기 위해 암 감시를 위해 지속적인 방사선 검사나 침습적 시술을 시행하는 것은 비현실적입니다. 액체생검은 정기적인 채혈과 소변 검사를 통한 정기적인 암 검진의 가능성을 열어줍니다. 암을 조기에 발견하기 위해 특이성이 높은 순환 마커를 식별할 수 있습니다.
액체생검은 암 환자의 치료 후 모니터링에도 사용됩니다. 암세포는 치료 후 영상 검사 해상도나 검출 수준보다 낮은 수준으로 체내에 남아있을 수 있는데, 이 상태를 미세잔존병변이라고 합니다. 이 질환은 암 관해의 주요 원인으로 여겨지고 있습니다. 암 검진 및 조기 발견과 마찬가지로 액체생검의 임상 적용은 현재 검사의 민감도와 특이도에 의해 제한되고 있습니다. 그러나 이러한 민감도의 한계로 인해 액체생검 기술은 혈액암보다 고형암의 미세 잔존 병변을 검출하는 데 더 유용하게 사용될 수 있습니다. 액체생검의 도움으로 의료 전문가는 암 재발 사례를 모니터링하고 적절한 진단을 통해 조기에 치료할 수 있습니다.
게피티닙, 엘로티닙, 크리조티닙, 세리티닙과 같은 특정 티로신 키나아제 억제제에 처음에 민감했던 종양은 종종 돌연변이를 일으켜 이러한 약물에 대한 내성을 갖게 됩니다. 액체생검은 종양 상태의 변화를 감지하여 의사가 환자의 몸에서 어떤 약물에 대한 내성이 생기지 않도록 치료 전략을 수정하는 데 도움이 됩니다. 이처럼 액체생검은 암을 조기에 발견하고 의료진이 정확한 치료 방침을 결정하는 데 도움을 줄 수 있습니다. 또한 치료 및 치료 후 환자의 상태를 모니터링하는 데에도 도움이 됩니다. 이처럼 암 환자 모니터링에 대한 액체생검의 활용에 대한 관심이 높아지면서 예측 기간 중 액체생검 시술용 채혈관에 대한 수요가 크게 증가할 것으로 보입니다.
제품별 인사이트
제품별로 액체생검용 채혈관 시장은 ccfDNA 채혈관, cfRNA 채혈관, CTC 채혈관, gDNA 채혈관, 세포내 RNA 채혈관, 기타로 나뉘며, ccfDNA/cfDNA 채혈관 부문이 2023년 가장 큰 시장 점유율을 차지했습니다.
재료별 인사이트
재료에 따라 액체생검용 채혈관 시장은 유리와 플라스틱으로 나뉩니다.
용도별 인사이트
액체생검용 채혈관 세계 시장은 용도별로 체외진단(IVD)과 연구로 구분되며, 2023년에는 체외진단 부문이 시장에서 더 큰 점유율을 차지할 가능성이 높습니다.
최종사용자별 인사이트
최종사용자별로 액체생검용 채혈 튜브 시장은 유전자 진단 실험실, R&D 센터, 기존 진단센터, 기타로 구분됩니다.
액체생검용 채혈관 시장 경쟁 구도 및 주요 발전 상황
Biocept Inc, F. Hoffmann-La Roche Ltd, Streck Inc, Norgen Biotek Corp, Exact Sciences Corp, MagBio Genomics, Inc, Zymo Research Corporation, Apostle Sciences, QIAGEN NV, Greiner Bio-One International GmbH 등이 액체생검용 채혈관 시장에서 사업을 운영하는 주요 기업입니다.
미국 식품의약국, 미국 질병통제예방센터(CDC), 세계질병부담조사(WCDC)는 액체생검용 채혈관 시장 보고서를 작성할 때 참고한 1차 및 2차 정보 중 하나입니다.
목차
제1장 서론
제2장 개요
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 액체생검용 채혈관 시장 구도
- PEST 분석
제5장 액체생검용 채혈관 시장 - 주요 시장 역학
- 액체생검용 채혈관 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 암의 유병률 증가
- 기타 진단 검사 기술에 대한 액체생검의 우위성
- 시장 성장 억제요인
- 숙련 전문가의 부족
- 시장 기회
- 암모니터링에서 액체생검의 이용
- 향후 동향
- 액체생검에서 기술의 진보
- 촉진요인과 억제요인의 영향
제6장 액체생검용 채혈관 시장 : 세계 시장 분석
- 액체생검용 채혈관 시장 매출(2021-2031년)
- 액체생검용 채혈관 시장 예측 분석
제7장 액체생검용 채혈관 시장 분석 - 제품별
- ccfDNA/cfDNA 채혈관
- cfRNA 채혈관
- CTC 채혈관
- gDNA 채혈관
- 세포내 RNA 채혈관
- 기타
제8장 액체생검용 채혈관 시장 분석 - 재료별
- 플라스틱
- 유리
제9장 액체생검용 채혈관 시장 분석 - 용도별
- 체외진단(IVD)
- 연구
제10장 액체생검용 채혈관 시장 분석 - 최종사용자별
- 유전자 진단 실험실
- 연구개발 센터
- 기존형 진단 센터
- 기타
제11장 액체생검용 채혈관 시장 - 지역별 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
- 중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제12장 액체생검용 채혈관 시장 : 업계 상황
- 액체생검용 채혈관 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
제13장 기업 개요
- Biocept Inc
- F. Hoffmann-La Roche Ltd
- Streck Inc
- Norgen Biotek Corp
- Exact Sciences Corp
- MagBio Genomics, Inc
- Zymo Research Corporation
- Apostle Sciences
- QIAGEN NV
- Greiner Bio-One International GmbH
제14장 부록
KSA 24.10.16According to our new research study on "Blood Collection Tubes for Liquid Biopsy Market Forecast to 2031 - Global Analysis - by Product, Application, Material, End User, and Geography," the market is anticipated to grow from US$ 110.13 million in 2023 and is projected to reach US$ 428.66 million by 2031; it is expected to register a CAGR of 18.5% during 2023-2031. An increase in the prevalence of cancer worldwide and the advantages of liquid biopsy over other diagnostic testing techniques are among the most influential factors responsible for the blood collection tubes for liquid biopsy market growth. However, a lack of skilled professionals hinders the market growth. Technological advancements in liquid biopsy are expected to bring new blood collection tubes for liquid biopsy market trends in the coming years.
Blood Collection Tubes for Liquid Biopsy are among the most promising avenues in the pharmaceutical industry, offering a unique approach to treating various diseases and medical conditions. The blood collection tubes for liquid biopsy market is constantly growing because pharma and biotechnology companies enormously invest in improving their production facilities. The increasing number of cases and diagnoses of chronic diseases requires the availability of sophisticated diagnostic and treatment drugs, which has boosted the global blood collection tubes for liquid biopsy market. Furthermore, rising demand, higher acceptance of innovative therapies, and increasing clinical trials are expected to drive market growth. However, approving biosimilars is one of the main aspects limiting the blood collection tubes for liquid biopsy market expansion.
North America accounted for a major share of the global blood collection tubes for liquid biopsy market in 2023. The blood collection tube for liquid biopsy market in North America is segmented into the US, Canada, and Mexico. The burgeoning acceptance of technologically advanced products, a rise in research and development activities, the presence of large-scale healthcare businesses, and the increasing number of approvals from the FDA for liquid biopsy are among the key factors bolstering the blood collection tube for liquid biopsy market in North America. The market for liquid biopsy procedures is growing rapidly in the US with the surging prevalence of cancer, high spending on the development of innovative diagnostics solutions, and the presence of significant market players in the country. The National Cancer Institute estimates that ~2 million new cases of cancer would be registered in the US in 2024, and ~611,720 people are expected to die due to cancer. As per the same source, ~440.5 per 100,000 people are nearly diagnosed with cancer every year. Tissue biopsies are highly invasive techniques employed for lung cancer diagnosis. As the insufficiency of samples may result in nonreliable results in this type of biopsy, researchers focus on the development of liquid biopsy techniques for lung cancer diagnoses. In December 2022, Agilent Technologies Inc. received approval from the US FDA for Agilent Resolution ctDx FIRST as a companion diagnostics (CDx) solution to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations, who may benefit from the KRAZATI (adagrasib) treatment. Such approvals from the US FDA of liquid biopsy tests would propel the demand for blood collection tubes for liquid biopsy in the US.
Use of Liquid Biopsy in Cancer Monitoring to Provide Market Opportunities in Future
There is a growing focus on employing liquid biopsy procedures for monitoring cancer growth, detecting genetic mutations, identifying signs of relapse, and predicting sensitivity to immunotherapy. The early detection of cancer results in better outcomes; for example, patients with early detection show higher remission and survival rates than those with late-stage or malignant cancer. However, it is impractical to perform serial radiological testing or invasive procedures for cancer surveillance to detect cancer in the early stages when symptoms are not evident. Liquid biopsy unlocks the possibility of periodic cancer screening through routine blood draws or urinalyses. It can identify highly specific and circulating markers for early cancer detection.
Liquid biopsy procedures are also employed for post-treatment monitoring of cancer patients. Cancer cells may persist in the body after treatment at levels below the resolution and detection levels of imaging studies; the condition is termed a minimal residual disease. This disease is considered a principal cause of cancer remission. Similar to that in cancer screening and early detection, the clinical application of liquid biopsy is limited by the sensitivity and specificity of current tests. However, due to this sensitivity limitation, liquid biopsy techniques can be used for detecting minimal residual disease for solid tumors than blood cancers. With the help of liquid biopsy, the healthcare professional can monitor the case of reoccurrence of cancer, which can then be treated early with the help of proper diagnosis.
Tumors that are initially susceptible to specific tyrosine kinase inhibitors, including gefitinib, erlotinib, crizotinib, and ceritinib, often mutate and develop resistance to these drugs. Liquid biopsy detects the changes in the tumor status and helps doctors modify the treatment strategies to avoid the development of resistance to any medication in the patient's body. Thus, liquid biopsy allows the early detection of cancer and helps healthcare professionals determine the exact course of action for treatment. In addition, it helps monitor treatments and the condition of the patient after the treatment. Thus, there is an increase in focus on the use of liquid biopsy in the monitoring of cancer patients, which is likely to create a significant demand for blood collection tubes for liquid biopsy procedures during the forecast period.
Product -Based Insights
Based on product, the blood collection tubes for liquid biopsy market is divided into ccfDNA tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. The ccfDNA/cfDNA tubes segment held the largest market share in 2023.
Material -Based Insights
Based on material, the blood collection tubes for liquid biopsy market is divided into glass and plastic.
Application -Based Insights
The global blood collection tubes for liquid biopsy market, based on appplication is segmented into In-Vitro Diagnostics (IVD), and research. In 2023, the in-vitro diagnostics segment is likely to hold a larger share of the market.
End User -Based Insights
Based on end user, the blood collection tubes for liquid biopsy market is divided into genetic diagnostic labs, R&D centers, conventional diagnostic centers, and others.
Blood Collection Tubes for Liquid Biopsy Market: Competitive Landscape and Key Developments
Biocept Inc, F. Hoffmann-La Roche Ltd; Streck Inc; Norgen Biotek Corp; Exact Sciences Corp; MagBio Genomics, Inc; Zymo Research Corporation; Apostle Sciences; QIAGEN NV; and Greiner Bio-One International GmbH are among the key companies operating in the blood collection tubes for liquid biopsy market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the blood collection tubes for liquid biopsy market report.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Blood Collection Tubes for Liquid Biopsy Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
- 5.1 Blood Collection Tubes for Liquid Biopsy Market - Key Market Dynamics
- 5.2 Market Drivers:
- 5.2.1 Increase in Prevalence of Cancer
- 5.2.2 Advantages of Liquid Biopsy Over Other Diagnostic Testing Techniques
- 5.3 Market Restraints
- 5.3.1 Lack of Skilled Professionals
- 5.4 Market Opportunities
- 5.4.1 Use of Liquid Biopsy in Cancer Monitoring
- 5.5 Future Trends
- 5.5.1 Technological Advancements in Liquid Biopsy
- 5.6 Impact of Drivers and Restraints:
6. Blood Collection Tubes for Liquid Biopsy Market - Global Market Analysis
- 6.1 Blood Collection Tubes for Liquid Biopsy Market Revenue (US$ Thousand), 2021-2031
- 6.2 Blood Collection Tubes for Liquid Biopsy Market Forecast Analysis
7. Blood Collection Tubes for Liquid Biopsy Market Analysis - by Product
- 7.1 ccfDNA/cfDNA Tubes
- 7.1.1 Overview
- 7.1.2 ccfDNA/cfDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 7.2 cfRNA Tubes
- 7.2.1 Overview
- 7.2.2 cfRNA Tubes: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 7.3 CTC Tubes
- 7.3.1 Overview
- 7.3.2 CTC Tubes: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 7.4 gDNA Tubes
- 7.4.1 Overview
- 7.4.2 gDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 7.5 Intracellular RNA Tubes
- 7.5.1 Overview
- 7.5.2 Intracellular RNA Tubes: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
8. Blood Collection Tubes for Liquid Biopsy Market Analysis - by Material
- 8.1 Plastic
- 8.1.1 Overview
- 8.1.2 Plastic: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 8.2 Glass
- 8.2.1 Overview
- 8.2.2 Glass: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
9. Blood Collection Tubes for Liquid Biopsy Market Analysis - by Application
- 9.1 In-vitro Diagnostics (IVD)
- 9.1.1 Overview
- 9.1.2 In-vitro Diagnostics (IVD): Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 9.2 Research
- 9.2.1 Overview
- 9.2.2 Research: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
10. Blood Collection Tubes for Liquid Biopsy Market Analysis - by End User
- 10.1 Genetic Diagnostic Labs
- 10.1.1 Overview
- 10.1.2 Genetic Diagnostic Labs: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 10.2 Research and Development Centres
- 10.2.1 Overview
- 10.2.2 Research and Development Centres: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 10.3 Conventional Diagnostic Centres
- 10.3.1 Overview
- 10.3.2 Conventional Diagnostic Centres: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
11. Blood Collection Tubes for Liquid Biopsy Market - Geographical Analysis
- 11.1 Overview
- 11.2 North America
- 11.2.1 North America Blood Collection Tubes for Liquid Biopsy Market Overview
- 11.2.2 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.2.1 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Product
- 11.2.2.2 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Material
- 11.2.2.3 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Application
- 11.2.2.4 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by End User
- 11.2.3 North America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
- 11.2.3.1 United States: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.3.1.1 United States: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.2.3.1.2 United States: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.2.3.1.3 United States: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.2.3.1.4 United States: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.2.3.2 Canada: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.3.2.1 Canada: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.2.3.2.2 Canada: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.2.3.2.3 Canada: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.2.3.2.4 Canada: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.2.3.3 Mexico: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.2.3.3.1 Mexico: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.2.3.3.2 Mexico: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.2.3.3.3 Mexico: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.2.3.3.4 Mexico: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.2.3.1 United States: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3 Europe
- 11.3.1 Europe Blood Collection Tubes for Liquid Biopsy Market Overview
- 11.3.2 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.2.1 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Product
- 11.3.2.2 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Material
- 11.3.2.3 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Application
- 11.3.2.4 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by End User
- 11.3.3 Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
- 11.3.3.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.1.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.1.2 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.1.3 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.1.4 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.2 Germany: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.2.1 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.2.2 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.2.3 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.2.4 Germany: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.3 France: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.3.1 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.3.2 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.3.3 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.3.4 France: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.4 Italy: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.4.1 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.4.2 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.4.3 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.4.4 Italy: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.5 Spain: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.5.1 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.5.2 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.5.3 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.5.4 Spain: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.6 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.3.3.6.1 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.3.3.6.2 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.3.3.6.3 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.3.3.6.4 Rest of Europe: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.3.3.1 United Kingdom: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4 Asia Pacific
- 11.4.1 Asia Pacific Blood Collection Tubes for Liquid Biopsy Market Overview
- 11.4.2 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.2.1 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Product
- 11.4.2.2 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Material
- 11.4.2.3 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Application
- 11.4.2.4 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by End User
- 11.4.3 Asia Pacific: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
- 11.4.3.1 China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.1.1 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.1.2 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.1.3 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.1.4 China: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.2 Japan: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.2.1 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.2.2 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.2.3 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.2.4 Japan: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.3 India: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.3.1 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.3.2 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.3.3 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.3.4 India: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.4 Australia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.4.1 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.4.2 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.4.3 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.4.4 Australia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.5 South Korea: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.5.1 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.5.2 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.5.3 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.5.4 South Korea: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.6 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.4.3.6.1 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.4.3.6.2 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.4.3.6.3 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.4.3.6.4 Rest of APAC: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.4.3.1 China: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5 Middle East and Africa
- 11.5.1 Middle East and Africa Blood Collection Tubes for Liquid Biopsy Market Overview
- 11.5.2 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5.2.1 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Product
- 11.5.2.2 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Material
- 11.5.2.3 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Application
- 11.5.2.4 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by End User
- 11.5.3 Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
- 11.5.3.1 South Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5.3.1.1 South Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.5.3.1.2 South Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.5.3.1.3 South Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.5.3.1.4 South Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.5.3.2 Saudi Arabia: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5.3.2.1 Saudi Arabia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.5.3.2.2 Saudi Arabia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.5.3.2.3 Saudi Arabia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.5.3.2.4 Saudi Arabia: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.5.3.3 United Arab Emirates: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5.3.3.1 United Arab Emirates: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.5.3.3.2 United Arab Emirates: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.5.3.3.3 United Arab Emirates: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.5.3.3.4 United Arab Emirates: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.5.3.4 Rest of Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.5.3.4.1 Rest of Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.5.3.4.2 Rest of Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.5.3.4.3 Rest of Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.5.3.4.4 Rest of Middle East and Africa: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.5.3.1 South Africa: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.6 South and Central America
- 11.6.1 South and Central America Blood Collection Tubes for Liquid Biopsy Market Overview
- 11.6.2 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.6.2.1 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Product
- 11.6.2.2 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Material
- 11.6.2.3 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Application
- 11.6.2.4 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by End User
- 11.6.3 South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast Analysis - by Country
- 11.6.3.1 Brazil: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.6.3.1.1 Brazil: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.6.3.1.2 Brazil: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.6.3.1.3 Brazil: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.6.3.1.4 Brazil: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.6.3.2 Argentina: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.6.3.2.1 Argentina: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.6.3.2.2 Argentina: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.6.3.2.3 Argentina: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.6.3.2.4 Argentina: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.6.3.3 Rest of South and Central America: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
- 11.6.3.3.1 Rest of South and Central America: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Product
- 11.6.3.3.2 Rest of South and Central America: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Material
- 11.6.3.3.3 Rest of South and Central America: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by Application
- 11.6.3.3.4 Rest of South and Central America: Blood Collection Tubes for Liquid Biopsy Market Breakdown, by End User
- 11.6.3.1 Brazil: Blood Collection Tubes for Liquid Biopsy Market - Revenue and Forecast to 2031 (US$ Thousand)
12. Blood Collection Tubes for Liquid Biopsy Market - Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in Blood Collection Tubes for Liquid Biopsy Market
- 12.3 Organic Growth Strategies
- 12.3.1 Overview
- 12.4 Inorganic Growth Strategies
- 12.4.1 Overview
13. Company Profiles
- 13.1 Biocept Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 F. Hoffmann-La Roche Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Streck Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Norgen Biotek Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Exact Sciences Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 MagBio Genomics, Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Zymo Research Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Apostle Sciences
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 QIAGEN NV
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Greiner Bio-One International GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 About The Insight Partners
